APEXLENS CO., LTD.

APEXLENS Co., Ltd. specializes in silicone hydrogel soft contact lenses, specifically designed for daily wear. Their primary product line, such as the ComfyArt Silicone Hydrogel One Day Soft Contact Lenses, is intended for single-use applications. These lenses provide optical correction while prioritizing comfort and safety for extended wear periods.

APEXLENS Co., Ltd. is headquartered in Taiwan. While the company’s location determines its primary regulatory jurisdiction (e.g., Taiwan’s regulatory framework), its devices intended for the European market are classified under EU regulations. This includes registration in the EUDAMED database, which is a transparent public resource for tracking medical devices authorized within the EU.

APEXLENS Co., Ltd.’s devices fall under the EU Class IIa classification. This classification is assigned based on the risk associated with the device—Class IIa includes products like contact lenses that pose moderate risks but are still considered safe when used as intended. The classification influences the regulatory requirements, such as the need for a Conformité Européenne (CE) marking and compliance with EU Medical Device Regulation (MDR) or Medical Device Directive (MDD) standards before market placement.

APEXLENS Co., Ltd.’s devices are listed in the EUDAMED database, which is the European Union’s official registry for medical devices. This database serves as a public resource to track devices that have undergone the necessary authorization processes (e.g., CE marking) to be legally marketed within the EU. Listing in EUDAMED ensures transparency and allows stakeholders to verify the regulatory status of the company’s products.